Cargando…
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after k...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560294/ https://www.ncbi.nlm.nih.gov/pubmed/34733559 http://dx.doi.org/10.1155/2021/5497346 |
_version_ | 1784592913420779520 |
---|---|
author | Li, Yin Sha, Zixin Peng, Hui |
author_facet | Li, Yin Sha, Zixin Peng, Hui |
author_sort | Li, Yin |
collection | PubMed |
description | Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases. |
format | Online Article Text |
id | pubmed-8560294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-85602942021-11-02 Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities Li, Yin Sha, Zixin Peng, Hui Int J Nephrol Review Article Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases. Hindawi 2021-10-25 /pmc/articles/PMC8560294/ /pubmed/34733559 http://dx.doi.org/10.1155/2021/5497346 Text en Copyright © 2021 Yin Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Li, Yin Sha, Zixin Peng, Hui Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
title | Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
title_full | Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
title_fullStr | Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
title_full_unstemmed | Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
title_short | Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities |
title_sort | metabolic reprogramming in kidney diseases: evidence and therapeutic opportunities |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560294/ https://www.ncbi.nlm.nih.gov/pubmed/34733559 http://dx.doi.org/10.1155/2021/5497346 |
work_keys_str_mv | AT liyin metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities AT shazixin metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities AT penghui metabolicreprogramminginkidneydiseasesevidenceandtherapeuticopportunities |